{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:16:37Z","timestamp":1793218597297,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Living Biotherapeutic Products (LBPs) offer a promising therapeutic strategy for metabolic disorders rooted in gut microbiome dysfunction, yet quantitative frameworks for predicting their efficacy remain underdeveloped. We introduce the Bacterial Compartment Absorption and Transit (BCAT) model, a pharmacokinetic-pharmacodynamic framework that couples probiotic transit, endogenous microbiome metabolism, and enzymatic transformation within a unified dose-optimization setting. Building on the classical CAT model, BCAT incorporates mechanistically-derived colon compartments and treats dosing time as a control variable. We validate BCAT against clinical data for native choline metabolism and SYNB1618 probiotic trials, achieving 5% mean prediction error compared to ~30% for prior two-compartment models. Applying BCAT to trimethylaminuria (TMAU), we predict that ~10\n                    <jats:sup>9<\/jats:sup>\n                    CFU of engineered probiotic, administered 3\u20134\u2009h before meals, achieves 95% reduction in systemic trimethylamine, matching healthy hepatic clearance. Global sensitivity analysis identifies enzyme expression level as the dominant design parameter, enforcing the broad applicability of this model. The BCAT framework generalizes to any gut microbiome-mediated metabolic disorder and provides quantitative dosing targets to guide live biotherapeutic development.\n                  <\/jats:p>","DOI":"10.1038\/s41540-026-00685-4","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:05:18Z","timestamp":1774310718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Signed, sealed, delivered: a generalizable model for living biotherapeutic dosing and metabolism"],"prefix":"10.1038","volume":"12","author":[{"given":"Vicenzo L.","family":"DeVito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargav R.","family":"Karamched","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"685_CR1","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1021\/acssynbio.9b00146","volume":"8","author":"RN Alnahhas","year":"2019","unstructured":"Alnahhas, R. N. et al. Spatiotemporal dynamics of synthetic microbial consortia in microfluidic devices. ACS Synth. Biol. 8, 2051\u20132058 (2019).","journal-title":"ACS Synth. Biol."},{"key":"685_CR2","first-page":"100085","volume":"2","author":"R Godin","year":"2022","unstructured":"Godin, R., Karamched, B. R. & Ryan, S. D. The space between us: modeling spatial heterogeneity in synthetic microbial consortia dynamics. Biophys. Rep. 2, 100085 (2022).","journal-title":"Biophys. Rep."},{"key":"685_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2018.02.023","volume":"275","author":"YF Bueso","year":"2018","unstructured":"Bueso, Y. F., Lehouritis, P. & Tangney, M. In situ biomolecule production by bacteria; a synthetic biology approach to medicine. J. Controlled Release 275, 217\u2013228 (2018).","journal-title":"J. Controlled Release"},{"key":"685_CR4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41578-021-00315-x","volume":"6","author":"J Wang","year":"2021","unstructured":"Wang, J., Li, Y. & Nie, G. Multifunctional biomolecule nanostructures for cancer therapy. Nat. Rev. Mater. 6, 766\u2013783 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"685_CR5","doi-asserted-by":"crossref","unstructured":"Sarup, R. & Singh, N. Smart therapeutics: evolution from small biomolecules to synthetic cells. Nanomed. Transl. Res. 271\u2013290 (2025).","DOI":"10.1016\/B978-0-443-22257-3.00012-X"},{"key":"685_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.sbi.2008.06.006","volume":"18","author":"K Channon","year":"2008","unstructured":"Channon, K., Bromley, E. H. & Woolfson, D. N. Synthetic biology through biomolecular design and engineering. Curr. Opin. Struct. Biol. 18, 491\u2013498 (2008).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"685_CR7","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1002\/ibd.21565","volume":"17","author":"ZZ Hamady","year":"2011","unstructured":"Hamady, Z. Z. et al. Treatment of colitis with a commensal gut bacterium engineered to secrete human tgf-\u03b21 under the control of dietary xylan. Inflamm. Bowel Dis. 17, 1925\u20131935 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"685_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.appet.2015.12.011","volume":"98","author":"J Darzi","year":"2016","unstructured":"Darzi, J., Frost, G. S., Swann, J. R., Costabile, A. & Robertson, M. D. L-rhamnose as a source of colonic propionate inhibits insulin secretion but does not influence measures of appetite or food intake. Appetite 98, 142\u2013149 (2016).","journal-title":"Appetite"},{"key":"685_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/msb.2011.55","volume":"7","author":"N Saeidi","year":"2011","unstructured":"Saeidi, N. et al. Engineering microbes to sense and eradicate pseudomonas aeruginosa, a human pathogen. Mol. Syst. Biol. 7, 521 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"685_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-015-0198-4","volume":"14","author":"LG Berm\u00fadez-Humar\u00e1n","year":"2015","unstructured":"Berm\u00fadez-Humar\u00e1n, L. G. et al. Serine protease inhibitors protect better than il-10 and tgf-\u03b2 anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci. Microb. Cell Factories 14, 1\u201311 (2015).","journal-title":"Microb. Cell Factories"},{"key":"685_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1126\/scitranslmed.3004212","volume":"4","author":"J-P Motta","year":"2012","unstructured":"Motta, J.-P. et al. Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci. Transl. Med. 4, 158\u2013144158144 (2012).","journal-title":"Sci. Transl. Med."},{"key":"685_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/mi.2009.116","volume":"3","author":"K Vandenbroucke","year":"2010","unstructured":"Vandenbroucke, K. et al. Orally administered l. lactis secreting an anti-tnf nanobody demonstrate efficacy in chronic colitis. Mucosal Immunol. 3, 49\u201356 (2010).","journal-title":"Mucosal Immunol."},{"key":"685_CR13","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","volume":"289","author":"L Steidler","year":"2000","unstructured":"Steidler, L. et al. Treatment of murine colitis by lactococcus lactis secreting interleukin-10. Science 289, 1352\u20131355 (2000).","journal-title":"Science"},{"key":"685_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MCG.0000000000000235","volume":"48","author":"S Del Carmen","year":"2014","unstructured":"Del Carmen, S. et al. Protective effects of lactococci strains delivering either il-10 protein or cDNA in a tnbs-induced chronic colitis model. J. Clin. Gastroenterol. 48, 12\u201317 (2014).","journal-title":"J. Clin. Gastroenterol."},{"key":"685_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.intimp.2016.11.017","volume":"42","author":"S Del Carmen","year":"2017","unstructured":"Del Carmen, S. et al. Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or il-10 in a colorectal cancer mouse model. Int. Immunopharmacol. 42, 122\u2013129 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"685_CR16","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.2337\/db13-1236","volume":"63","author":"S Robert","year":"2014","unstructured":"Robert, S. et al. Oral delivery of glutamic acid decarboxylase (GAD)-65 and il10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. Diabetes 63, 2876\u20132887 (2014).","journal-title":"Diabetes"},{"key":"685_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/gut.2008.176131","volume":"59","author":"ZZ Hamady","year":"2010","unstructured":"Hamady, Z. Z. et al. Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut 59, 461\u2013469 (2010).","journal-title":"Gut"},{"key":"685_CR18","doi-asserted-by":"publisher","first-page":"1700159","DOI":"10.1002\/biot.201700159","volume":"13","author":"J Dou","year":"2018","unstructured":"Dou, J. & Bennett, M. R. Synthetic biology and the gut microbiome. Biotechnol. J. 13, 1700159 (2018).","journal-title":"Biotechnol. J."},{"key":"685_CR19","doi-asserted-by":"crossref","unstructured":"Sharma, S. & Kaur, J. The evolution of diabetes treatments: from insulin therapy to synthetic biology. Curr.Sci. 126, 6 (2024).","DOI":"10.18520\/cs\/v126\/i6\/662-670"},{"key":"685_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ymthe.2016.11.008","volume":"25","author":"S Xue","year":"2017","unstructured":"Xue, S. et al. A synthetic-biology-inspired therapeutic strategy for targeting and treating hepatogenous diabetes. Mol. Ther. 25, 443\u2013455 (2017).","journal-title":"Mol. Ther."},{"key":"685_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nchembio.975","volume":"8","author":"CM Agapakis","year":"2012","unstructured":"Agapakis, C. M., Boyle, P. M. & Silver, P. A. Natural strategies for the spatial optimization of metabolism in synthetic biology. Nat. Chem. Biol. 8, 527\u2013535 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"685_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/pr.2014.170","volume":"77","author":"Y Sanz","year":"2015","unstructured":"Sanz, Y., Olivares, M., Moya-P\u00e9rez, \u00c1 & Agostoni, C. Understanding the role of gut microbiome in metabolic disease risk. Pediatr. Res. 77, 236\u2013244 (2015).","journal-title":"Pediatr. Res."},{"key":"685_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.advnut.2023.03.015","volume":"14","author":"J Montenegro","year":"2023","unstructured":"Montenegro, J. et al. Exploring the influence of gut microbiome on energy metabolism in humans. Adv. Nutr. 14, 840\u2013857 (2023).","journal-title":"Adv. Nutr."},{"key":"685_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.chom.2023.01.009","volume":"31","author":"EM Brown","year":"2023","unstructured":"Brown, E. M., Clardy, J. & Xavier, R. J. Gut microbiome lipid metabolism and its impact on host physiology. Cell Host Microbe 31, 173\u2013186 (2023).","journal-title":"Cell Host Microbe"},{"key":"685_CR25","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1111\/1365-2656.13327","volume":"89","author":"EC Lindsay","year":"2020","unstructured":"Lindsay, E. C., Metcalfe, N. B. & Llewellyn, M. S. The potential role of the gut microbiota in shaping host energetics and metabolic rate. J. Anim. Ecol. 89, 2415\u20132426 (2020).","journal-title":"J. Anim. Ecol."},{"key":"685_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.aaw0542","volume":"365","author":"MJ Liao","year":"2019","unstructured":"Liao, M. J., Din, M. O., Tsimring, L. & Hasty, J. Rock-paper-scissors: engineered population dynamics increase genetic stability. Science 365, 1045\u20131049 (2019).","journal-title":"Science"},{"key":"685_CR27","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41589-019-0372-9","volume":"15","author":"JK Kim","year":"2019","unstructured":"Kim, J. K. et al. Long-range temporal coordination of gene expression in synthetic microbial consortia. Nat. Chem. Biol. 15, 1102\u20131109 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"685_CR28","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1126\/science.aaa3794","volume":"349","author":"Y Chen","year":"2015","unstructured":"Chen, Y., Kim, J. K., Hirning, A. J., Josi\u0107, K. & Bennett, M. R. Emergent genetic oscillations in a synthetic microbial consortium. Science 349, 986\u2013989 (2015).","journal-title":"Science"},{"key":"685_CR29","doi-asserted-by":"publisher","first-page":"1009381","DOI":"10.1371\/journal.pcbi.1009381","volume":"17","author":"JJ Winkle","year":"2021","unstructured":"Winkle, J. J., Karamched, B. R., Bennett, M. R., Ott, W. & Josi\u0107, K. Emergent spatiotemporal population dynamics with cell-length control of synthetic microbial consortia. PLoS Comput. Biol. 17, 1009381 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"685_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.physd.2019.02.001","volume":"395","author":"B Karamched","year":"2019","unstructured":"Karamched, B. et al. Moran model of spatial alignment in microbial colonies. Phys. D: Nonlinear Phenom. 395, 1\u20136 (2019).","journal-title":"Phys. D: Nonlinear Phenom."},{"key":"685_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0378-5173(96)04592-9","volume":"140","author":"XY Lawrence","year":"1996","unstructured":"Lawrence, X. Y., Crison, J. R. & Amidon, G. L. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans. Int. J. Pharm. 140, 111\u2013118 (1996).","journal-title":"Int. J. Pharm."},{"key":"685_CR32","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10928-007-9066-0","volume":"34","author":"RM Savic","year":"2007","unstructured":"Savic, R. M., Jonker, D. M., Kerbusch, T. & Karlsson, M. O. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J. Pharmacokinet. Pharmacodyn. 34, 711\u2013726 (2007).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"685_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0378-5173(99)00147-7","volume":"186","author":"XY Lawrence","year":"1999","unstructured":"Lawrence, X. Y. & Amidon, G. L. A compartmental absorption and transit model for estimating oral drug absorption. Int. J. Pharm. 186, 119\u2013125 (1999).","journal-title":"Int. J. Pharm."},{"key":"685_CR34","doi-asserted-by":"crossref","unstructured":"LeVeque, R.J. Finite Volume Methods for Hyperbolic Problems, 31 (Cambridge University Press, 2002).","DOI":"10.1017\/CBO9780511791253"},{"key":"685_CR35","doi-asserted-by":"crossref","unstructured":"LeVeque, R.J. Finite difference methods for ordinary and partial differential equations: steady-state and time-dependent problems. SIAM, (2007).","DOI":"10.1137\/1.9780898717839"},{"key":"685_CR36","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/jps.2600730922","volume":"73","author":"J Dressman","year":"1984","unstructured":"Dressman, J., Fleisher, D. & Amidon, G. Physicochemical model for dose-dependent drugabsorption. J. Pharm. Sci. 73, 1274\u20131279 (1984).","journal-title":"J. Pharm. Sci."},{"key":"685_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/BF01061761","volume":"15","author":"RL Oberle","year":"1987","unstructured":"Oberle, R. L. & Amidon, G. L. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon. J. Pharmacokinet. Biopharm. 15, 529\u2013544 (1987).","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"685_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0169-409X(01)00179-X","volume":"50","author":"B Agoram","year":"2001","unstructured":"Agoram, B., Woltosz, W. S. & Bolger, M. B. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv. drug Deliv. Rev. 50, 41\u201367 (2001).","journal-title":"Adv. drug Deliv. Rev."},{"key":"685_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1208\/s12248-008-9054-3","volume":"10","author":"M Kuentz","year":"2008","unstructured":"Kuentz, M. Drug absorption modeling as a tool to define the strategy in clinical formulation development. AAPS J. 10, 473\u2013479 (2008).","journal-title":"AAPS J."},{"key":"685_CR40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s42003-021-02183-1","volume":"4","author":"MR Charbonneau","year":"2021","unstructured":"Charbonneau, M. R. et al. Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria. Commun. Biol. 4, 898 (2021).","journal-title":"Commun. Biol."},{"key":"685_CR41","doi-asserted-by":"publisher","first-page":"10539","DOI":"10.15252\/msb.202110539","volume":"18","author":"D Lubkowicz","year":"2022","unstructured":"Lubkowicz, D. et al. An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria. Mol. Syst. Biol. 18, 10539 (2022).","journal-title":"Mol. Syst. Biol."},{"key":"685_CR42","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1002\/btpr.3125","volume":"37","author":"ZJ Mays","year":"2021","unstructured":"Mays, Z. J. & Nair, N. U. A quantitative model for metabolic intervention using gut microbes. Biotechnol. Prog. 37, 3125 (2021).","journal-title":"Biotechnol. Prog."},{"key":"685_CR43","first-page":"33","volume":"32","author":"RJ Mackay","year":"2011","unstructured":"Mackay, R. J., McEntyre, C. J., Henderson, C., Lever, M. & George, P. M. Trimethylaminuria: causes and diagnosis of a socially distressing condition. Clin. Biochem. Rev. 32, 33 (2011).","journal-title":"Clin. Biochem. Rev."},{"key":"685_CR44","first-page":"45","volume":"6","author":"J Messenger","year":"2013","unstructured":"Messenger, J., Clark, S., Massick, S. & Bechtel, M. A review of trimethylaminuria:(fish odor syndrome). J. Clin. Aesthetic Dermatol. 6, 45 (2013).","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"685_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2022.06.344","volume":"355","author":"P Day-Walsh","year":"2022","unstructured":"Day-Walsh, P. et al. Investigating mechanisms of tma production from choline, l-carnitine and related precursors by the human gut microbiota using of an in-vitro batch fermentation (human colon) model. Atherosclerosis 355, 40 (2022).","journal-title":"Atherosclerosis"},{"key":"685_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-017-0271-9","volume":"5","author":"S Rath","year":"2017","unstructured":"Rath, S., Heidrich, B., Pieper, D. H. & Vital, M. Uncovering the trimethylamine-producing bacteria of the human gut microbiota. Microbiome 5, 1\u201314 (2017).","journal-title":"Microbiome"},{"key":"685_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/msystems.00945-21","volume":"6","author":"S Rath","year":"2021","unstructured":"Rath, S. et al. Higher trimethylamine-N-oxide plasma levels with increasing age are mediated by diet and trimethylamine-forming bacteria. MSystems 6, 10\u20131128 (2021).","journal-title":"MSystems"},{"key":"685_CR48","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s00394-022-02803-4","volume":"61","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Circulating trimethylamine N-oxide levels following fish or seafood consumption. Eur. J. Nutr. 61, 2357\u20132364 (2022).","journal-title":"Eur. J. Nutr."},{"key":"685_CR49","unstructured":"Awosika, A.O. & Anastasopoulou, C. Trimethylaminuria. In: StatPearls. StatPearls Publishing, Treasure Island (FL) https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK594255\/ (2023)."},{"key":"685_CR50","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/ejhg.2014.226","volume":"23","author":"EA Shephard","year":"2015","unstructured":"Shephard, E. A., Treacy, E. P. & Phillips, I. R. Clinical utility gene card for: Trimethylaminuria\u2013update 2014. Eur. J. Hum. Genet. 23, 1269 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"685_CR51","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.drudis.2020.06.026","volume":"25","author":"AC Schmidt","year":"2020","unstructured":"Schmidt, A. C. & Leroux, J.-C. Treatments of trimethylaminuria: where we are and where we might be heading. Drug Discov. Today 25, 1710\u20131717 (2020).","journal-title":"Drug Discov. Today"},{"key":"685_CR52","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","volume":"24","author":"AB Roberts","year":"2018","unstructured":"Roberts, A. B. et al. Development of a gut microbe\u2013targeted nonlethal therapeutic to inhibit thrombosis potential. Nat. Med. 24, 1407\u20131417 (2018).","journal-title":"Nat. Med."},{"key":"685_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0461-0","volume":"6","author":"L Hoyles","year":"2018","unstructured":"Hoyles, L. et al. Metabolic retroconversion of trimethylamine n-oxide and the gut microbiota. Microbiome 6, 73 (2018).","journal-title":"Microbiome"},{"key":"685_CR54","doi-asserted-by":"publisher","first-page":"63998","DOI":"10.7554\/eLife.63998","volume":"11","author":"RC Schugar","year":"2022","unstructured":"Schugar, R. C. et al. Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms. Elife 11, 63998 (2022).","journal-title":"Elife"},{"key":"685_CR55","doi-asserted-by":"publisher","first-page":"17791","DOI":"10.1073\/pnas.1112928108","volume":"108","author":"Y Chen","year":"2011","unstructured":"Chen, Y., Patel, N. A., Crombie, A., Scrivens, J. H. & Murrell, J. C. Bacterial flavin-containing monooxygenase is trimethylamine monooxygenase. Proc. Natl. Acad. Sci.USA 108, 17791\u201317796 (2011).","journal-title":"Proc. Natl. Acad. Sci.USA"},{"key":"685_CR56","doi-asserted-by":"publisher","first-page":"0170742","DOI":"10.1371\/journal.pone.0170742","volume":"12","author":"W Stremmel","year":"2017","unstructured":"Stremmel, W. et al. Blood trimethylamine-n-oxide originates from microbiota mediated breakdown of phosphatidylcholine and absorption from small intestine. PLoS ONE 12, 0170742 (2017).","journal-title":"PLoS ONE"},{"key":"685_CR57","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3920\/BM2016.0140","volume":"8","author":"A Ouwehand","year":"2017","unstructured":"Ouwehand, A. A review of dose-responses of probiotics in human studies. Benef. Microbes 8, 143\u2013151 (2017).","journal-title":"Benef. Microbes"},{"key":"685_CR58","doi-asserted-by":"publisher","first-page":"240","DOI":"10.7326\/M18-0343","volume":"169","author":"A Bafeta","year":"2018","unstructured":"Bafeta, A., Koh, M., Riveros, C. & Ravaud, P. Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: a systematic review. Ann. Intern. Med. 169, 240\u2013247 (2018).","journal-title":"Ann. Intern. Med."},{"key":"685_CR59","doi-asserted-by":"publisher","first-page":"109464","DOI":"10.1016\/j.mbs.2025.109464","volume":"386","author":"ZO Dere","year":"2025","unstructured":"Dere, Z. O., Cogan, N. G. & Karamched, B. R. Optimal control strategies for mitigating antibiotic resistance: integrating virus dynamics for enhanced intervention design. Math. Biosci. 386, 109464 (2025).","journal-title":"Math. Biosci."},{"key":"685_CR60","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0378-4754(00)00270-6","volume":"55","author":"IM Sobol","year":"2001","unstructured":"Sobol, I. M. Global sensitivity indices for nonlinear mathematical models and their Monte Carlo estimates. Math. Comput. Simul. 55, 271\u2013280 (2001).","journal-title":"Math. Comput. Simul."},{"key":"685_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cpc.2009.09.018","volume":"181","author":"A Saltelli","year":"2010","unstructured":"Saltelli, A. et al. Variance-based sensitivity analysis of model output. design and estimator for the total sensitivity index. Comput. Phys. Commun. 181, 259\u2013270 (2010).","journal-title":"Comput. Phys. Commun."},{"key":"685_CR62","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s11538-017-0329-7","volume":"79","author":"AM Jarrett","year":"2017","unstructured":"Jarrett, A. M., Cogan, N. & Hussaini, M. Combining two methods of global sensitivity analysis to investigate mrsa nasal carriage model. Bull. Math. Biol. 79, 2258\u20132272 (2017).","journal-title":"Bull. Math. Biol."},{"key":"685_CR63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11538-024-01288-y","volume":"86","author":"KI Gasior","year":"2024","unstructured":"Gasior, K. I. & Cogan, N. G. Untangling the molecular interactions underlying intracellular phase separation using combined global sensitivity analyses. Bull. Math. Biol. 86, 60 (2024).","journal-title":"Bull. Math. Biol."},{"key":"685_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0016-5085(87)90837-7","volume":"92","author":"AM Metcalf","year":"1987","unstructured":"Metcalf, A. M. et al. Simplified assessment of segmental colonic transit. Gastroenterology 92, 40\u201347 (1987).","journal-title":"Gastroenterology"},{"key":"685_CR65","first-page":"180","volume":"20","author":"EB Minelli","year":"2008","unstructured":"Minelli, E. B. & Benini, A. Relationship between number of bacteria and their probiotic effects. Microb. Ecol. Health Dis. 20, 180\u2013183 (2008).","journal-title":"Microb. Ecol. Health Dis."},{"key":"685_CR66","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1007\/s00394-021-02572-6","volume":"60","author":"P Day-Walsh","year":"2021","unstructured":"Day-Walsh, P. et al. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of tma production from choline, l-carnitine and related precursors by the human gut microbiota. Eur. J. Nutr. 60, 3987\u20133999 (2021).","journal-title":"Eur. J. Nutr."},{"key":"685_CR67","first-page":"904","volume":"38","author":"J De La Huerga","year":"1951","unstructured":"De La Huerga, J., Popper, H. & Steigmann, F. Urinary excretion of choline and trimethylamines after intravenous administration of choline in liver diseases. J. Lab. Clin. Med. 38, 904\u2013910 (1951).","journal-title":"J. Lab. Clin. Med."},{"key":"685_CR68","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0022-3565(25)33590-1","volume":"225","author":"SH Zeisel","year":"1983","unstructured":"Zeisel, S. H., Wishnok, J. S. & Blusztajn, J. K. Formation of methylamines from ingested choline and lecithin. J. Pharmacol. Exp. Ther. 225, 320\u2013324 (1983).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"685_CR69","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0278-6915(99)00028-9","volume":"37","author":"A Zhang","year":"1999","unstructured":"Zhang, A., Mitchell, S. & Smith, R. Dietary precursors of trimethylamine in man: a pilot study. Food Chem. Toxicol. 37, 515\u2013520 (1999).","journal-title":"Food Chem. Toxicol."},{"key":"685_CR70","doi-asserted-by":"crossref","unstructured":"Chastaing, G., Gamboa, F. & Prieur, C. Generalized Hoeffding-Sobol decomposition for dependent variables-application to sensitivity analysis. Electron. J. Statist. 6, 2420\u20132448 (2012).","DOI":"10.1214\/12-EJS749"},{"key":"685_CR71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11538-024-01308-x","volume":"86","author":"M Aggarwal","year":"2024","unstructured":"Aggarwal, M., Lewis, O., Jarrett, A., Hussaini, M. & Cogan, N. A model of gastric mucosal ph regulation: extending sensitivity analysis using sobol\u2019indices to understand higher moments. Bull. Math. Biol. 86, 77 (2024).","journal-title":"Bull. Math. Biol."},{"key":"685_CR72","doi-asserted-by":"crossref","unstructured":"Da Veiga, S., Gamboa, F., Iooss, B. & Prieur, C. Basics and Trends in Sensitivity Analysis: Theory and Practice in R. SIAM (2021).","DOI":"10.1137\/1.9781611976694"},{"key":"685_CR73","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1080\/00949655.2014.960415","volume":"85","author":"G Chastaing","year":"2015","unstructured":"Chastaing, G., Gamboa, F. & Prieur, C. Generalized Sobol sensitivity indices for dependent variables: numerical methods. J. Stat. Comput. Simul. 85, 1306\u20131333 (2015).","journal-title":"J. Stat. Comput. Simul."},{"key":"685_CR74","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.envsoft.2011.06.006","volume":"34","author":"E Borgonovo","year":"2012","unstructured":"Borgonovo, E., Castaings, W. & Tarantola, S. Model emulation and moment-independent sensitivity analysis: an application to environmental modelling. Environ. Model. Softw. 34, 105\u2013115 (2012).","journal-title":"Environ. Model. Softw."},{"key":"685_CR75","doi-asserted-by":"publisher","first-page":"108593","DOI":"10.1016\/j.mbs.2021.108593","volume":"337","author":"M Renardy","year":"2021","unstructured":"Renardy, M., Joslyn, L. R., Millar, J. A. & Kirschner, D. E. To sobol or not to sobol? the effects of sampling schemes in systems biology applications. Math. Biosci. 337, 108593 (2021).","journal-title":"Math. Biosci."},{"key":"685_CR76","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ejor.2012.11.047","volume":"226","author":"E Plischke","year":"2013","unstructured":"Plischke, E., Borgonovo, E. & Smith, C. L. Global sensitivity measures from given data. Eur. J. Operat. Res. 226, 536\u2013550 (2013).","journal-title":"Eur. J. Operat. Res."},{"key":"685_CR77","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/risa.12555","volume":"36","author":"E Borgonovo","year":"2016","unstructured":"Borgonovo, E., Hazen, G. B. & Plischke, E. A common rationale for global sensitivity measures and their estimation. Risk Anal. 36, 1871\u20131895 (2016).","journal-title":"Risk Anal."},{"key":"685_CR78","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2307\/1403510","volume":"62","author":"S M Blower","year":"1994","unstructured":"Blower, S. M. & Dowlatabadi, H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int. Stat. Rev.\/Rev. Int. Stat 62, 229\u2013243 (1994).","journal-title":"Int. Stat. Rev.\/Rev. Int. Stat"},{"key":"685_CR79","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/gut.29.1.85","volume":"29","author":"J Siegel","year":"1988","unstructured":"Siegel, J. et al. Biphasic nature of gastric emptying. Gut 29, 85\u201389 (1988).","journal-title":"Gut"},{"key":"685_CR80","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1081\/DDC-120005623","volume":"28","author":"A Crowe","year":"2002","unstructured":"Crowe, A., Lockman, P., Abbruscato, T. & Allen, D. Novel choline transport characteristics in Caco-2 cells. Drug Dev. Ind. Pharm. 28, 773\u2013781 (2002).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"685_CR81","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2131\/jts.43.387","volume":"43","author":"M Shimizu","year":"2018","unstructured":"Shimizu, M. et al. Human plasma concentrations of trimethylamine n-oxide extrapolated using pharmacokinetic modeling based on metabolic profiles of deuterium-labeled trimethylamine in humanized-liver mice. J. Toxicol. Sci. 43, 387\u2013393 (2018).","journal-title":"J. Toxicol. Sci."},{"key":"685_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-4-32","volume":"4","author":"MR Dyson","year":"2004","unstructured":"Dyson, M. R., Shadbolt, S. P., Vincent, K. J., Perera, R. L. & McCafferty, J. Production of soluble mammalian proteins in Escherichia coli: identification of protein features that correlate with successful expression. BMC Biotechnol. 4, 32 (2004).","journal-title":"BMC Biotechnol."},{"key":"685_CR83","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0167-4889(92)90226-2","volume":"1135","author":"M Hu","year":"1992","unstructured":"Hu, M. & Borchardt, R. T. Transport of a large neutral amino acid in a human intestinal epithelial cell line (Caco-2): uptake and efflux of phenylalanine. Biochim. et. Biophys. Acta (BBA)-Mol. Cell Res. 1135, 233\u2013244 (1992).","journal-title":"Biochim. et. Biophys. Acta (BBA)-Mol. Cell Res."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00685-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T08:02:52Z","timestamp":1775462572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00685-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1038\/s41540-026-00685-4","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}